Market revenue in 2023 | USD 2.8 million |
Market revenue in 2030 | USD 4.7 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Transrectal |
Fastest growing segment | Transperineal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transrectal, Transperineal |
Key market players worldwide | Koninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.
Transrectal was the largest segment with a revenue share of 85.71% in 2023. Horizon Databook has segmented the UAE fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing incidence of prostate cancer and technological advancements in fusion biopsy are expected to contribute to market growth. According to the International Agency for Research on Cancer, 252 new cases were reported in 2018. Moreover, the growing geriatric population is expected to contribute to market growth over the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into UAE fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account